Research Article

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer

Table 3

Univariate analysis and multivariate analysis in the training set.

VariablesUnivariate analysisMultivariate analysis
HR95% CI valueHR95% CI value

SexMaleref
Female1.1200.693-1.8120.644
Age (median, y)590.9960.978-1.0140.658
Tumour siteLeftref
Right1.0660.663-1.7120.793
BMI (kg/m2)21.31.0010.964-1.0390.957
Tumour diameter5.30.9800.970-1.1050.745
ASA grade1/2ref
30.7110.495-1.1100.425
ComorbiditiesAbsentref
Present1.0110.799-1.1030.375
Intestinal obstructionAbsentref
Present0.6660.395-1.1200.125
PLR2061.0010.999-1.0030.295
NLR3.21.0020.976-1.0280.906
CAR<0.14refref
≥0.141.7851.086-2.9330.0222.2711.345-3.8340.002
CEA (median)0.21.0021.001-1.0040.0111.0021.001-1.0030.002
CA199 (median)11.991.0021.001-1.004<0.001
Postoperative chemotherapyAbsentref
Present2.5611.584-4.140<0.001
Operation modeOpenrefref
Laparoscopic0.5800.360-0.9340.0250.6010.368-0.9800.041
LNDs190.9830.608-1.5910.944
LNMAbsentrefref
Present2.5611.584-4.140<0.0012.5451.530-4.235<0.001
T-stageT1-2ref
T30.8790.625-1.237
T40.9130.589-1.4150.048
LVIAbsentref
Present2.1781.341-3.5380.002
PNIAbsentrefref
Present2.4261.384-4.2520.0020.6010.368-0.9800.012

LND: lymph node dissection; LNM: lymph node metastasis; LVI: lymphovascular invasion; PNI: perineural invasion.